BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026)
BioAge Labs (BIOA) reported Gains from Investment Securities of $107000.0 for Q1 2026, up 281.36% on a YoY basis from $28057.8 in Q1 2025, and down 51.36% sequentially from $220000.0 in Q4 2025.
BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 3 years of Gains from Investment Securities data on file, last reported at $107000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 281.36% year-over-year to $107000.0; the trailing twelve-month figure through Mar 2026 stood at $380000.0 (up 371.43% YoY), and the FY2025 full-year result was $214000.0, up 393.15% from the prior year.
- Gains from Investment Securities eased to $107000.0 in Q1 2026, from $220000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $306000.0 in Q3 2024 to a low of -$457000.0 in Q4 2024.
- A 3-year average of $27555.6 and a median of $42000.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities plunged 837.5% in 2025 and jumped 281.36% in 2026, its largest moves.
- Tracing BIOA's Gains from Investment Securities over 3 years: stood at -$457000.0 in 2024, then jumped by 148.14% to $220000.0 in 2025, then plunged by 51.36% to $107000.0 in 2026.
- Business Quant data shows BIOA's Gains from Investment Securities at $107000.0 in Q1 2026, $220000.0 in Q4 2025, and $42000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | BioAge Labs | 912.48 Mn | 912.48 Mn | -10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Dec 31, 2024 | -457,000.00 |
| Dec 31, 2024 | -457,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |